Aflatrem
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Category | Mycotoxins |
Catalog number | BBF-04462 |
CAS | 70553-75-2 |
Molecular Weight | 501.66 |
Molecular Formula | C32H39NO4 |
Purity | 98.0% |
Online Inquiry
Description
Aflatrem is the secondary metabolite of Aspergillus flavus. It is able to induce degeneration of neuronal processes in hippocampal neurotransmitter systems at low dose. It potentiates the gamma-aminobutyric acid (GABA)-induced chloride current. It is a tremorgenic mycotoxin with acute neurotoxic effect.
Specification
Synonyms | 4H-3,15a-Epoxy-1-benzoxepino[6',7':6,7]indeno[1,2-b]indol-4-one, 9-(1,1-dimethyl-2-propenyl)-2,3,5b,6,7,7a,8,13,13b,13c,14,15-dodecahydro-5b-hydroxy-2,2,13b,13c-tetramethyl-, (3R,5bS,7aS,13bS,13cR,15aS)-; 9-(1,1-Dimethyl-2-propenyl)-2,3,5b,6,7,7aα,8,13,13b,13c,14,15-dodecahydro-5bβ-hydroxy-2,2,13bβ,13cα-tetramethyl-4H-3β,15aβ-epoxy-1-benzoxepino[6',7':6,7]indeno[1,2-b]indol-4-one; α,α-dimethylallylpaspalinine |
Storage | Store at -20°C |
IUPAC Name | (1S,4R,5S,16S,19S,23R)-19-hydroxy-4,5,24,24-tetramethyl-12-(2-methylbut-3-en-2-yl)-25,26-dioxa-7-azaheptacyclo[21.2.1.01,20.04,19.05,16.06,14.08,13]hexacosa-6(14),8,10,12,20-pentaen-22-one |
Canonical SMILES | CC1(C2C(=O)C=C3C4(CCC5CC6=C(C5(C4(CCC3(O2)O1)C)C)NC7=CC=CC(=C67)C(C)(C)C=C)O)C |
InChI | InChI=1S/C32H39NO4/c1-8-27(2,3)20-10-9-11-21-24(20)19-16-18-12-13-31(35)23-17-22(34)26-28(4,5)37-32(23,36-26)15-14-29(31,6)30(18,7)25(19)33-21/h8-11,17-18,26,33,35H,1,12-16H2,2-7H3/t18-,26-,29+,30+,31+,32-/m0/s1 |
InChI Key | YVDJBQQJIDPRKP-SLUQHKSNSA-N |
Source | Aflatrem is a tremorgenic mycotoxin that has been found in the fungus Aspergillus flavus. |
Properties
Appearance | Yellow Needles |
Boiling Point | 663.6±55.0°C at 760 mmHg |
Melting Point | 222-224°C |
Density | 1.3±0.1 g/cm3 |
Solubility | Soluble in Chloroform, Methanol |
Toxicity
Carcinogenicity | No indication of carcinogenicity to humans (not listed by IARC). |
Mechanism Of Toxicity | Tremorgenic mycotoxins exert their toxic effects by interfering with neurotransmitter release, possibly by causing degeneration of nerve terminals. They are thought to inhibit gamma-aminobutyric acid (GABA) receptors, both pre- and postsynaptic, as well as inhibit transmitter breakdown at the GABA-T receptors. This would initially increase neurotransmitter levels, potentiating the GABA-induced chloride current, then lead to decreased levels of neurotransmitter in the synapse. In addition, aflatrem inhibits presynaptic high-conductance Ca+2 activated maxi-K+ channels in the smooth muscle. |
Reference Reading
Spectrum
Predicted LC-MS/MS Spectrum - 10V, Positive
Experimental Conditions
Collision Energy: 10 eV
Instrument Type: QTOF (generic), spectrum predicted by CFM-ID
Mass Resolution: 0.0001 Da
Molecular Formula: C32H39NO4
Molecular Weight (Monoisotopic Mass): 501.2879 Da
Molecular Weight (Avergae Mass): 501.6564 Da
Recommended Products
BBF-05763 | Cyclosporin C | Inquiry |
BBF-01829 | Deoxynojirimycin | Inquiry |
BBF-03819 | Spinosyn A | Inquiry |
BBF-00703 | Carminomycin I | Inquiry |
BBF-04013 | Tildipirosin | Inquiry |
BBF-01729 | Hygromycin B | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2